Literature DB >> 28663715

Personalized radiotherapy treatment planning based on functional imaging.

Malgorzata Skórska1, Tomasz Piotrowski1,2.   

Abstract

In recent years, a huge progress in the field of radiotherapy could be observed. From treating patients with kilo-voltage X-rays units to cutting edge technology that can deliver a certain dose with an extreme precision. Modern radiotherapy is characterized, among others, by an individualized approach to the patient. This can be provided by functional imaging which is another step toward a better tumor control. In this paper, we discuss the potential application of functional imaging modalities in personalized radiotherapy planning with emphasis on dose painting. Some limitations of this approach will also be evaluated.

Entities:  

Keywords:  Dose painting; Functional imaging; PET; Radiotherapy; fMRI

Year:  2017        PMID： 28663715      PMCID： PMC5472268          DOI： 10.1016/j.rpor.2017.04.002

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN： 1507-1367


  39 in total

1.  Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush.

Authors:  Gert Meijer; Jacco Steenhuijsen; Matthieu Bal; Katrien De Jaeger; Danny Schuring; Jacqueline Theuws
Journal:  Radiother Oncol       Date:  2011-09-28       Impact factor: 6.280

2.  Adaptive dose painting by numbers for head-and-neck cancer.

Authors:  Fréderic Duprez; Wilfried De Neve; Werner De Gersem; Marc Coghe; Indira Madani
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-17       Impact factor: 7.038

3.  Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.

Authors:  Piet Dirix; Vincent Vandecaveye; Frederik De Keyzer; Sigrid Stroobants; Robert Hermans; Sandra Nuyts
Journal:  J Nucl Med       Date:  2009-06-12       Impact factor: 10.057

4.  Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: Analysis of quality of life and toxicity, PCG GU 002.

Authors:  Carlos Enrique Vargas; William Fred Hartsell; Megan Dunn; Sameer Ramchandra Keole; Lucius Doh; John Chang; Gary Lynn Larson
Journal:  Rep Pract Oncol Radiother       Date:  2016-03-04

5.  Feasibility and sensitivity study of helical tomotherapy for dose painting plans.

Authors:  Michael A Deveau; Stephen R Bowen; David C Westerly; Robert Jeraj
Journal:  Acta Oncol       Date:  2010-10       Impact factor: 4.089

6.  The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer.

Authors:  Wouter van Elmpt; Dirk De Ruysscher; Anke van der Salm; Annemarie Lakeman; Judith van der Stoep; Daisy Emans; Eugène Damen; Michel Öllers; Jan-Jakob Sonke; José Belderbos
Journal:  Radiother Oncol       Date:  2012-04-06       Impact factor: 6.280

7.  Hypoxia and radiation therapy: past history, ongoing research, and future promise.

Authors:  Sara Rockwell; Iwona T Dobrucki; Eugene Y Kim; S Tucker Marrison; Van Thuc Vu
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

8.  Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.

Authors:  Alexandra Deviers; Soléakhéna Ken; Thomas Filleron; Benjamin Rowland; Andrea Laruelo; Isabelle Catalaa; Vincent Lubrano; Pierre Celsis; Isabelle Berry; Giovanni Mogicato; Elizabeth Cohen-Jonathan Moyal; Anne Laprie
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-08-04       Impact factor: 7.038

9.  Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer.

Authors:  Daniela Thorwarth; Susanne-Martina Eschmann; Jutta Scheiderbauer; Frank Paulsen; Markus Alber
Journal:  BMC Cancer       Date:  2005-12-01       Impact factor: 4.430

10.  A new plan quality index for dose painting radiotherapy.

Authors:  Yang-Kyun Park; Soyeon Park; Hong-Gyun Wu; Siyong Kim
Journal:  J Appl Clin Med Phys       Date:  2014-07-08       Impact factor: 2.102
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.